These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15503370)

  • 1. MultiHance in brain tumor imaging.
    Jansen O
    Eur Radiol; 2004 Jun; 14 Suppl 7():O5-9; discussion O20-1. PubMed ID: 15503370
    [No Abstract]   [Full Text] [Related]  

  • 2. MultiHance in brain perfusion.
    Essig M
    Eur Radiol; 2004 Jun; 14 Suppl 7():O10-5; discussion O20-1. PubMed ID: 15503371
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
    Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
    J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
    [No Abstract]   [Full Text] [Related]  

  • 4. High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors.
    Pinker K; Noebauer-Huhmann IM; Stavrou I; Hoeftberger R; Szomolanyi P; Weber M; Stadlbauer A; Grabner G; Knosp E; Trattnig S
    Neuroradiology; 2008 Jan; 50(1):9-16. PubMed ID: 17876570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.
    Aronen HJ; Peltonen TK; Tanttu JI; Sipilä LM; Ruhala MT; Jääskeläinen J; Sepponen R
    Acad Radiol; 1996 Aug; 3 Suppl 2():S170-2. PubMed ID: 8796553
    [No Abstract]   [Full Text] [Related]  

  • 6. MultiHance in cardiac magnetic resonance imaging.
    Schneider G; Saedi D; Massmann A; Fries P; Boehm M; Kramann B; Winter H
    Eur Radiol; 2004 Jun; 14 Suppl 7():O71-9; discussion O84-5. PubMed ID: 15503380
    [No Abstract]   [Full Text] [Related]  

  • 7. MultiHance and state-of-the-art contrast-enhanced MRI.
    Spinazzi A
    Eur Radiol; 2004 Jun; 14 Suppl 7():O87-8. PubMed ID: 15503382
    [No Abstract]   [Full Text] [Related]  

  • 8. MultiHance in multiple sclerosis: update of a study in progress.
    Tartaro A
    Eur Radiol; 2004 Jun; 14 Suppl 7():O16-9; discussion O20-1. PubMed ID: 15503372
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the efficacy of gadobutrol and multihance in contrast-enhanced MRI for diagnosis of brain metastasis in lung cancer].
    Li ZL; Chen X; Xia CC; Sun JY; Li CX; Tang HH; Song B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 43(4):601-4. PubMed ID: 22997905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MultiHance-enhanced MRI in the characterisation of focal liver lesions.
    Leen E
    Eur Radiol; 2004 Jun; 14 Suppl 7():O31-5; discussion O41-2. PubMed ID: 15503374
    [No Abstract]   [Full Text] [Related]  

  • 12. High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings.
    Pinker K; Noebauer-Huhmann IM; Stavrou I; Hoeftberger R; Szomolanyi P; Karanikas G; Weber M; Stadlbauer A; Knosp E; Friedrich K; Trattnig S
    AJNR Am J Neuroradiol; 2007 Aug; 28(7):1280-6. PubMed ID: 17698528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of contrast behavior of gadobenate-dimeglumine and Gd-DTPA in intra-axial brain tumors. A double-blind randomized intraindividual cross-over study].
    Essig M; Hartmann M; Lodemann KP; Jansen O; Seeberg A; Runge VM; Knopp MV
    Radiologe; 2001 Dec; 41(12):1063-71. PubMed ID: 11793931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation between T1 relaxation times before and after administration of contrast media in malignant brain tumors.
    Niemi P; Aronen HJ; Kwong KK; Gazit IE; Pardo FS; Rosen BR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S286-8. PubMed ID: 8796582
    [No Abstract]   [Full Text] [Related]  

  • 15. MultiHance in the assessment of intracranial tumors: results of phase II clinical studies.
    Ruscalleda J; Kirchin MA; La Noce A; Pirovano G; Spinazzi A
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S19-27. PubMed ID: 10608394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MultiHance in liver lesion detection: personal experience.
    Grazioli L
    Eur Radiol; 2004 Jun; 14 Suppl 7():O25-30; discussion O41-2. PubMed ID: 15503373
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffusion-perfusion in intra-axial brain tumors with high relaxivity contrast agents.
    Cotton F
    Neuroradiology; 2006 Apr; 48 Suppl 1():34-40. PubMed ID: 16699850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
    Scherr MK; Seitz M; Müller-Lisse UG; Ingrisch M; Reiser MF; Müller-Lisse UL
    Eur J Radiol; 2010 Dec; 76(3):359-66. PubMed ID: 20471189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of MultiHance and Gadovist for cerebral MR perfusion imaging in healthy volunteers].
    Essig M; Lodemann KP; LeHuu M; Schönberg SO; Hübener M; Van Kaick G
    Radiologe; 2002 Nov; 42(11):909-15. PubMed ID: 12458444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.